特発性低身長
WordNet
- without possessing something at the time it is contractually sold; "he made his fortune by selling short just before the crash"
- the location on a baseball field where the shortstop is stationed
- low in stature; not tall; "he was short and stocky"; "short in stature"; "a short smokestack"; "a little man" (同)little
- lacking foresight or scope; "a short view of the problem"; "shortsighted policies"; "shortsighted critics derided the plan"; "myopic thinking" (同)shortsighted, unforesightful, myopic
- at a disadvantage; "I was caught short" (同)unawares
- (primarily spatial sense) having little length or lacking in length; "short skirts"; "short hair"; "the board was a foot short"; "a short toss"
- at some point or distance before a goal is reached; "he fell short of our expectations"
- clean across; "the cars axle snapped short"
- not holding securities or commodities that one sells in expectation of a fall in prices; "a short sale"; "short in cotton"
- of speech sounds or syllables of relatively short duration; "the English vowel sounds in `pat, `pet, `pit, `pot, putt are short"
- primarily temporal sense; indicating or being or seeming to be limited in duration; "a short life"; "a short flight"; "a short holiday"; "a short story"; "only a few short months"
- so as to interrupt; "She took him up short before he could continue"
- tending to crumble or break into flakes due to a large amount of shortening; "shortbread is a short crumbly cookie"; "a short flaky pie crust"
- high level of respect gained by impressive development or achievement; "a man of great stature"
- (of a standing person) the distance from head to foot (同)height
- (of diseases) arising from an unknown cause; "idiopathic epilepsy"
- the act of propping up with shores (同)shoring up, propping up
PrepTutorEJDIC
- (長さ・時間・距離などが)『短い』,近い・(人が)『背が低い』・(数量・期間などが)不足の』,乏しい;目標(標準)に達しない・(文などが)『簡潔な』,手短な・『そっけない』,ぞんぞいな,無愛想な・(ケーキなどが)かりかりする,さくさくする・(母音・音節が)短い;(詩の行の母音が)強勢のない・急に,突然・短いもの;欠けているもの・短篇映画(short movie, short subject) ・=short circuit・《複数形で》不足,欠損 / …‘を'短絡させる,ショートさせる / 短絡する,ショートする
- 『背』(せい),身長(height) / (身体の,また道徳的・知的な)発達,成長,進歩
- 特発性疾患の(病気の原因があいまいな,また不明な場合)
- 半ズボン,ショートパンツ / 《おもに米》(男物下着の)パンツ
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2017/05/23 20:25:09」(JST)
[Wiki en表示]
Idiopathic short stature |
Classification and external resources |
Specialty |
endocrinology |
ICD-10 |
E34.3 |
ICD-9-CM |
783.43 |
[edit on Wikidata]
|
Idiopathic short stature (ISS) refers to extreme short stature that does not have a diagnostic explanation (idiopathic designates a condition that is unexplained or not understood) after an ordinary growth evaluation. The term has been in use since at least 1975[1] without a precise percentile or statistical definition of "extreme".
Contents
- 1 Definition
- 2 Treatment
- 3 Advantage
- 4 See also
- 5 References
- 6 External links
Definition
In 2003 Eli Lilly and Company offered a more precise definition of ISS when the pharmaceutical company submitted clinical trial data to the U.S. Food and Drug Administration (FDA) requesting approval to advertise their brand of growth hormone for the treatment of ISS.[2] They proposed a definition of a height more than 2.25 standard deviations below mean, roughly equal to the shortest 1.2% of the population.
Other researchers have described a cutoff of 2.0 standard deviations.[3]
Treatment
There is some evidence that hormone treatment may not result in a significant improvement in psychosocial functioning.[4]
It is estimated that it would cost US$100,000 or more [5] to treat someone, but might only move them from the first percentile to perhaps the 10th. An ethical and economic question is would that just transfer the disadvantages to those in what was previously the "2nd" percentile?
The use of insulin-like growth factor 1[6] or aromatase inhibitors[7] have been proposed as an alternative to growth hormone.
Advantage
Short stature decrease risk of venous insufficiency[disambiguation needed].[8]
See also
References
- ^ Sizonenko PC, Rabinovitch A, Schneider P, Paunier L, Wollheim CB, Zahnd G (1975). "Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa". Pediatr. Res. 9 (9): 733–8. doi:10.1203/00006450-197509000-00010. PMID 1105371.
- ^ Leschek EW, Rose SR, Yanovski JA, et al. (2004). "Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial". J. Clin. Endocrinol. Metab. 89 (7): 3140–8. doi:10.1210/jc.2003-031457. PMID 15240584.
- ^ Bonioli E, Tarò M, Rosa CL, et al. (2005). "Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature". Growth Horm. IGF Res. 15 (6): 405–10. doi:10.1016/j.ghir.2005.08.004. PMID 16213173.
- ^ Visser-van Balen H, Sinnema G, Geenen R (2006). "Growing up with idiopathic short stature: psychosocial development and hormone treatment; a critical review". Arch. Dis. Child. 91 (5): 433–9. doi:10.1136/adc.2005.086942. PMC 2082749. PMID 16632673.
- ^ Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR (2006). "Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature". Arch Pediatr Adolesc Med. 160 (3): 263–9. doi:10.1001/archpedi.160.3.263. PMID 16520445.
- ^ Savage MO, Camacho-Hübner C, David A, et al. (2007). "Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?". Eur. J. Endocrinol. 157 Suppl 1: S33–7. doi:10.1530/EJE-07-0292. PMID 17785695.
- ^ Damiani D, Damiani D (2007). "Pharmacological management of children with short stature: the role of aromatase inhibitors". J Pediatr (Rio J). 83 (5 Suppl): S172–7. doi:10.2223/JPED.1699. PMID 17901908.
- ^ "'Tall height'".
External links
- Account of the FDA approval of Humatrope for ISS
- Excellent synopsis of GH use for ISS from the Minnesota Dept of Health
- National Organization of Short Statured Adults
Symptoms and signs relating to endocrine system, nutrition and development (R62–R64, 783)
|
|
Weight and appetite |
decrease: |
- Anorexia
- Weight loss
- Cachexia
- Underweight
|
|
increase: |
- Polyphagia
- Polydipsia
- Orexigenia
- Weight gain
|
|
|
Growth |
- Delayed milestone
- Failure to thrive
- Short stature
|
|
Thyroid disease |
General |
|
|
Graves' disease |
- Abadie's sign of exophthalmic goiter
- Boston's sign
- Dalrymple's sign
- Stellwag's sign
- lid lag
- Von Graefe's sign
- Griffith's sign
- Möbius sign
|
|
Hypothyroidism |
|
|
|
Nutrition |
- Rickets
- Benedict solution
|
|
Metabolic disorders |
- low calcium
- Chvostek sign
- Trosseau's sign
- low glucose
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A non-sense MCM9 mutation in a familial case of primary ovarian insufficiency.
- Fauchereau F1,2, Shalev S3,4, Chervinsky E3,4, Fruchter RB5, Legois B1,2, Fellous M6,7, Caburet S1,2, Veitia RA1,2.
- Clinical genetics.Clin Genet.2016 Jan 14. doi: 10.1111/cge.12736. [Epub ahead of print]
- Primary Ovarian Insufficiency (POI) results in an early loss of ovarian function, and remains idiopathic in about 80% of cases. Here, we have performed a complete genetic study of a consanguineous family with two POI cases. Linkage analysis and homozygosity mapping identified twelve homozygous regio
- PMID 26771056
- Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
- Cappa M1, Iughetti L2, Loche S3, Maghnie M4, Vottero A5; GeNeSIS National Board on behalf of the GeNeSIS Italian Investigators.
- Journal of endocrinological investigation.J Endocrinol Invest.2015 Dec 28. [Epub ahead of print]
- PURPOSE: We examined auxological changes in growth hormone (GH)-treated children in Italy using data from the Italian cohort of the multinational observational Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) of pediatric patients requiring GH treatment.METHODS: We stud
- PMID 26710758
- Duplications upstream and downstream of SHOX identified as novel causes of Leri-Weill dyschondrosteosis or idiopathic short stature.
- Bunyan DJ1, Baffico M2, Capone L3, Vannelli S4, Iughetti L5, Schmitt S6, Taylor EJ1, Herridge AA1, Shears D7, Forabosco A3, Coviello DA2.
- American journal of medical genetics. Part A.Am J Med Genet A.2015 Dec 24. doi: 10.1002/ajmg.a.37524. [Epub ahead of print]
- Leri-Weill dyschondrosteosis is a pseudoautosomal dominantly-inherited skeletal dysplasia ascribed to haploinsufficiency of the SHOX gene caused by deletions, point mutations, or partial duplications of the gene, or to heterozygous deletions upstream or downstream of the intact SHOX gene involving c
- PMID 26698168
Japanese Journal
- 成長ホルモン治療を行った特発性低身長症男性例の二次性徴
- 大山 建司,佐野 友昭,太田 正法 [他],小林 浩司,小林 基章,佐藤 和正,望月 美恵,三井 弓子,矢ケ崎 英晃,斉藤 朋洋,長嶺 健次郎,中込 美子
- 日本小児科学会雑誌 115(10), 1524-1530, 2011-10-01
- NAID 10029836371
- 臨床研究・症例報告 IGF-1 generation testに無反応だが成長ホルモン療法が著効した特発性低身長の1例
- Identification of 15 loci influencing height in a Korean population
- Kim Jae-Jung,Lee Hae-In,Park Taesung [他],KIM Kyunga,LEE Jong-Eun,CHO Nam Han,SHIN Chol,CHO Yoon Shin,LEE Jong-Young,HAN Bok-Ghee,YOO Han-Wook,LEE Jong-Keuk
- Journal of human genetics 55(1), 27-31, 2010-01-01
- NAID 10030733154
★リンクテーブル★
[★]
- 英
- idiopathic short stature
- 同
- idiopathic dwarfism
[show details]
[★]
[★]
- 英
- idiopathic short stature, ISS
[★]
- (比較級shorter-最上級shortest)短い、不足した、乏しい、省略された
- 関
- abbreviated、brevis、brief、dearth、deficit、in short、insufficiency、insufficient、lack、paucity、poor、scant、scanty、scarce、scarcity、shortage、shortness
[★]
- 関
- agnogenic、cryptogenic、idiopathy